For animals treated with mcr84 or GU81, we found that decreases in serum levels of IL-1β and IL-6 were highly correlative with changes in tumor size in the presence of anti-VEGF therapy (Fig. 8A–C). This evidence concerns the gene VEGFA and neoplasm.